Skip to content
Hexaminolevulinate
Cysview (hexaminolevulinate) is a small molecule pharmaceutical. Hexaminolevulinate was first approved as Cysview kit on 2010-05-28.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Cysview
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hexaminolevulinate hydrochloride
Tradename
Company
Number
Date
Products
CYSVIEW KITPhotocureN-022555 RX2010-05-28
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
cysviewNew Drug Application2020-08-17
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Hexaminolevulinate Hydrochloride, Cysview Kit, Photocure Asa
112351682038-01-04U-2250
105560102036-12-19U-2250
113116202036-12-19U-2250
ATC Codes
V: Various drug classes in atc
— V04: Diagnostic agents
— V04C: Other diagnostic agents in atc
— V04CX: Other diagnostic agents in atc
— V04CX06: Hexaminolevulinate
HCPCS
Code
Description
A9589
Instillation, hexaminolevulinate hydrochloride, 100 mg
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHEXAMINOLEVULINATE
INN—
Description
5-aminolevulinic acid hexyl ester is an organonitrogen compound and an organooxygen compound. It is functionally related to a delta-amino acid.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCCCCCOC(=O)CCC(=O)CN
Identifiers
PDB—
CAS-ID140898-97-1
RxCUI1426872
ChEMBL IDCHEMBL1201784
ChEBI ID—
PubChem CID6433083
DrugBankDB06261
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 517 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details